MiR-302b 靶向 Frizzled 6 抑制口腔鳞癌转移
该研究探讨 miR-302b 对口腔鳞状细胞癌(OSCC)侵袭和迁移的影响及机制。功能实验显示 miR-302b 水平与 OSCC 侵袭迁移能力负相关,过表达可减弱细胞侵袭迁移并减少小鼠模型淋巴管生成和肺转移率。机制研究证实 FZD6 是 miR-302b 的靶基因,可促进侵袭迁移;临床标本中 FZD6 蛋白在 OSCC 和转移淋巴结中高于正常口腔黏膜上皮。
要点
- miR-302b 水平与 OSCC 侵袭迁移能力负相关
- 过表达 miR-302b 可减少小鼠模型淋巴管生成和肺转移率
- FZD6 是 miR-302b 靶基因,在 OSCC 和转移淋巴结中高表达
核心结论
- miR-302b 通过靶向下调 FZD6 抑制 OSCC 细胞侵袭和迁移,从而抑制 OSCC 转移。
- FZD6 有潜力成为 OSCC 患者的预后和治疗靶点。
研究设计与样本
- 研究包含功能研究、机制研究(定量聚合酶链反应、荧光素酶实验和 RNA pull-down 实验)和临床研究。
- 功能研究分析 miR-302b 水平与 OSCC 侵袭迁移能力的相关性,并在小鼠模型中过表达 miR-302b。
- 临床研究比较 FZD6 蛋白在 OSCC、转移淋巴结和正常口腔黏膜上皮中的表达水平。
主要发现
- miR-302b 水平与 OSCC 侵袭和迁移能力呈负相关。
- 过表达 miR-302b 可减弱 OSCC 细胞的侵袭和迁移能力。
- 过表达 miR-302b 可减少小鼠模型中的淋巴管生成和 OSCC 细胞肺转移率。
- FZD6 是 miR-302b 在 OSCC 中的靶基因,可促进细胞侵袭和迁移。
- FZD6 蛋白在 OSCC 和转移淋巴结中的表达水平高于正常口腔黏膜上皮。
临床怎么用
- miR-302b 和 FZD6 可作为 OSCC 转移风险评估的潜在分子标志物。
- 靶向 miR-302b-FZD6 轴可能成为抑制 OSCC 转移的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oral squamous cell carcinoma (OSCC) accounts for approximately 90% of malignant epithelial tumors of the oral and maxillofacial region. OSCC has high rate of metastasis and poor prognosis. Tobacco and/or alcohol consumption and human papillomavirus infection are relatively exact susceptibility factors for OSCC, but the specific process of oral mucosal carcinogenesis and progression is very complicated. microRNA-302b (miR-302b) could regulate various characteristics of many tumor cells, such as proliferation and apoptosis, but its role and mechanism in OSCC have not been reported. This research aims to study the effect of miR-302b on the invasion and migration ability of OSCC and the mechanism by which it functions as well as to identify new prognostic indicators and therapeutic targets for OSCC patients. Functional studies showed that the miR-302b level was negatively correlated with the invasion and migration ability of OSCC. The studies also showed that the overexpression of miR-302b could attenuate the invasion and migration ability of OSCC cells and reduce lymphangiogenesis and the lung metastasis rate of OSCC cells in a mouse model. Mechanistic studies were performed by quantitative polymerase chain reactions, luciferase assays, and RNA pull-down experiments. The results verified that frizzled class receptor 6 (FZD6) is a target gene of miR-302b in OSCC that could promote cell invasion and migration. Clinical studies demonstrate that the protein expression level of FZD6 was higher in OSCC and metastatic lymph nodes than in normal oral mucosa epithelium. Taken together, these data showed that miR-302b could inhibit the invasion and migration ability of OSCC cells by targeting and downregulating FZD6, thereby inhibiting OSCC metastasis. As a new target gene of miR-302b, FZD6 has the potential to become a prognostic and therapeutic target for OSCC patients.
引用
- Sun S, Wang J, Liu J, et al. MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC. J Dent Res. 2021. PMID: 33478325. doi:10.1177/0022034520986551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。